Enhance Early Protocol Design with Evidence-Driven Insights

Are you applying data to help inform your protocol design? Learn how design analytics can help you make early, evidence-based decisions prior to protocol authoring, such as selecting the best endpoints. Discover how in this upcoming webinar!

Register Free: https://www.pharmexec.com/pe/evidence-driven

Event Overview:

Scarcity of data and siloed data sources lead to gaps in information that create challenges in study design. Additionally, the increase in trial complexity, which has seen a 600% increase in collected data points, contributes to a negative impact on a variety of trial performance outcomes. Evidence-based insights help study teams iterate upon ideas that can lead to lean study designs, resulting in reduced data points, decreased costs, and less deviations.

This webinar uncovers how technology and analytics can be applied to address key areas during study design/synopsis development. Learn how design analytics can help sponsors make early, in-flight design decisions prior to protocol authoring, such as selecting best endpoints, determining which eligibility criteria will improve probability of success, and identifying key regulatory design considerations.


Three key take-aways

• Discover how analytics can be applied to support decision making during early study design development.
• Discuss how to connect multiple tools and data sources to support design decisions prior to protocol authoring.
• Explore potential use cases where studies may benefit from evidence-driven study design.

Save the date! Webinar 2 in the series, How real-world data can optimize oncology clinical trial design will be presented on May 15, 2024 at 10:00am EST.

Speaker:

Tammie Nguyen
Design Analytics Director
IQVIA
Tammie Nguyen is a director of clinical planning and design analytics at IQVIA. She has over 10 years of clinical drug development experience, spanning from strategic design, protocol optimization, and operational planning through execution. Tammie has completed over 150 protocol assessments by using data to pressure test protocols, highlighting areas for protocol optimization before operationalization.

Tammie holds a BS in Biochemistry and Cell Biology from the University of California, San Diego, and a PharmD from Northeastern University. She also completed a post-doctoral fellowship at Eli Lilly and Company focused on drug development and trial execution. Currently, Tammie is leading the development of IQVIA’s Evidence-Driven Study Design solution.

Register Free: https://www.pharmexec.com/pe/evidence-driven